Danuta Pieniazek

Title: The Innovative Contributions of Danuta Pieniazek

Introduction

Danuta Pieniazek is a notable inventor based in Suwanee, Georgia, recognized for her significant contributions to the field of molecular detection. With a total of 2 patents, her work has advanced the understanding and diagnosis of viral infections, particularly HIV and adenoviruses.

Latest Patents

Pieniazek's latest patents include groundbreaking methods and reagents for the molecular detection of HIV-1 groups M, N, and O. These reagents consist of nucleic acid primers designed for hybridization, amplification, and detection of HIV-1 in biological samples. The high sensitivity of these assays allows for the detection of small concentrations of HIV, facilitating early diagnosis and effective monitoring of treatment regimens. Additionally, her patent on the detection of human adenovirus Type 41 focuses on the isolation of specific proteins and the development of diagnostic assays, DNA probes, and vaccines for this virus.

Career Highlights

Throughout her career, Pieniazek has worked with esteemed organizations such as Research Corporation Technologies, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. Her expertise in molecular biology and virology has positioned her as a key figure in the development of diagnostic tools for viral infections.

Collaborations

Pieniazek has collaborated with notable colleagues, including Norman J. Pieniazek and Susan B. Slemenda, contributing to a rich exchange of ideas and advancements in her field.

Conclusion

Danuta Pieniazek's innovative work in the detection of viral infections has made a significant impact on public health. Her patents reflect a commitment to advancing medical diagnostics and improving patient outcomes.